Integrating HIV services and other health services: A systematic review and meta-analysis.
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
02
01
2021
accepted:
05
10
2021
entrez:
9
11
2021
pubmed:
10
11
2021
medline:
22
12
2021
Statut:
epublish
Résumé
Integration of HIV services with other health services has been proposed as an important strategy to boost the sustainability of the global HIV response. We conducted a systematic and comprehensive synthesis of the existing scientific evidence on the impact of service integration on the HIV care cascade, health outcomes, and cost-effectiveness. We reviewed the global quantitative empirical evidence on integration published between 1 January 2010 and 10 September 2021. We included experimental and observational studies that featured both an integration intervention and a comparator in our review. Of the 7,118 unique peer-reviewed English-language studies that our search algorithm identified, 114 met all of our selection criteria for data extraction. Most of the studies (90) were conducted in sub-Saharan Africa, primarily in East Africa (55) and Southern Africa (24). The most common forms of integration were (i) HIV testing and counselling added to non-HIV services and (ii) non-HIV services added to antiretroviral therapy (ART). The most commonly integrated non-HIV services were maternal and child healthcare, tuberculosis testing and treatment, primary healthcare, family planning, and sexual and reproductive health services. Values for HIV care cascade outcomes tended to be better in integrated services: uptake of HIV testing and counselling (pooled risk ratio [RR] across 37 studies: 1.67 [95% CI 1.41-1.99], p < 0.001), ART initiation coverage (pooled RR across 19 studies: 1.42 [95% CI 1.16-1.75], p = 0.002), time until ART initiation (pooled RR across 5 studies: 0.45 [95% CI 0.20-1.00], p = 0.050), retention in HIV care (pooled RR across 19 studies: 1.68 [95% CI 1.05-2.69], p = 0.031), and viral suppression (pooled RR across 9 studies: 1.19 [95% CI 1.03-1.37], p = 0.025). Also, treatment success for non-HIV-related diseases and conditions and the uptake of non-HIV services were commonly higher in integrated services. We did not find any significant differences for the following outcomes in our meta-analyses: HIV testing yield, ART adherence, HIV-free survival among infants, and HIV and non-HIV mortality. We could not conduct meta-analyses for several outcomes (HIV infections averted, costs, and cost-effectiveness), because our systematic review did not identify sufficient poolable studies. Study limitations included possible publication bias of studies with significant or favourable findings and comparatively weak evidence from some world regions and on integration of services for key populations in the HIV response. Integration of HIV services and other health services tends to improve health and health systems outcomes. Despite some scientific limitations, the global evidence shows that service integration can be a valuable strategy to boost the sustainability of the HIV response and contribute to the goal of 'ending AIDS by 2030', while simultaneously supporting progress towards universal health coverage.
Sections du résumé
BACKGROUND
Integration of HIV services with other health services has been proposed as an important strategy to boost the sustainability of the global HIV response. We conducted a systematic and comprehensive synthesis of the existing scientific evidence on the impact of service integration on the HIV care cascade, health outcomes, and cost-effectiveness.
METHODS AND FINDINGS
We reviewed the global quantitative empirical evidence on integration published between 1 January 2010 and 10 September 2021. We included experimental and observational studies that featured both an integration intervention and a comparator in our review. Of the 7,118 unique peer-reviewed English-language studies that our search algorithm identified, 114 met all of our selection criteria for data extraction. Most of the studies (90) were conducted in sub-Saharan Africa, primarily in East Africa (55) and Southern Africa (24). The most common forms of integration were (i) HIV testing and counselling added to non-HIV services and (ii) non-HIV services added to antiretroviral therapy (ART). The most commonly integrated non-HIV services were maternal and child healthcare, tuberculosis testing and treatment, primary healthcare, family planning, and sexual and reproductive health services. Values for HIV care cascade outcomes tended to be better in integrated services: uptake of HIV testing and counselling (pooled risk ratio [RR] across 37 studies: 1.67 [95% CI 1.41-1.99], p < 0.001), ART initiation coverage (pooled RR across 19 studies: 1.42 [95% CI 1.16-1.75], p = 0.002), time until ART initiation (pooled RR across 5 studies: 0.45 [95% CI 0.20-1.00], p = 0.050), retention in HIV care (pooled RR across 19 studies: 1.68 [95% CI 1.05-2.69], p = 0.031), and viral suppression (pooled RR across 9 studies: 1.19 [95% CI 1.03-1.37], p = 0.025). Also, treatment success for non-HIV-related diseases and conditions and the uptake of non-HIV services were commonly higher in integrated services. We did not find any significant differences for the following outcomes in our meta-analyses: HIV testing yield, ART adherence, HIV-free survival among infants, and HIV and non-HIV mortality. We could not conduct meta-analyses for several outcomes (HIV infections averted, costs, and cost-effectiveness), because our systematic review did not identify sufficient poolable studies. Study limitations included possible publication bias of studies with significant or favourable findings and comparatively weak evidence from some world regions and on integration of services for key populations in the HIV response.
CONCLUSIONS
Integration of HIV services and other health services tends to improve health and health systems outcomes. Despite some scientific limitations, the global evidence shows that service integration can be a valuable strategy to boost the sustainability of the HIV response and contribute to the goal of 'ending AIDS by 2030', while simultaneously supporting progress towards universal health coverage.
Identifiants
pubmed: 34752477
doi: 10.1371/journal.pmed.1003836
pii: PMEDICINE-D-21-00012
pmc: PMC8577772
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1003836Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Drug Alcohol Depend. 2012 Oct 1;125(3):260-6
pubmed: 22436971
South Afr J HIV Med. 2018 Nov 26;19(1):826
pubmed: 30568836
Lancet Glob Health. 2020 Feb;8(2):e264-e275
pubmed: 31924539
Contemp Clin Trials. 2018 Sep;72:43-52
pubmed: 30053431
PLoS One. 2021 Jan 22;16(1):e0243822
pubmed: 33481776
Int J Qual Health Care. 2016 Dec 1;28(6):802-807
pubmed: 27655788
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219857977
pubmed: 31272314
J Int AIDS Soc. 2018 Mar;21(3):e25099
pubmed: 29577617
AIDS. 2021 Jun 1;35(7):1143-1146
pubmed: 33710025
Int J Drug Policy. 2019 Oct;72:160-168
pubmed: 31085063
Trop Med Int Health. 2018 Feb;23(2):136-148
pubmed: 29164754
Health Policy Plan. 2019 Jun 1;34(5):337-345
pubmed: 31157368
BMC Womens Health. 2015 Nov 13;15:104
pubmed: 26563220
Int J Tuberc Lung Dis. 2013 Dec;17(12):1558-63
pubmed: 24200268
BMC Res Notes. 2014 Mar 26;7:177
pubmed: 24670002
PLoS Med. 2021 Mar 31;18(3):e1003479
pubmed: 33789340
J Int AIDS Soc. 2019 Sep;22(9):e25381
pubmed: 31507088
PLoS One. 2015 Oct 29;10(10):e0141455
pubmed: 26513240
Lancet. 2012 Jul 28;380(9839):378-87
pubmed: 22819653
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv27-iv47
pubmed: 29106512
J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):522-526
pubmed: 29771779
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Public Health Rep. 2017 Nov/Dec;132(6):617-621
pubmed: 29045799
J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):115-9
pubmed: 21546845
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S2-7
pubmed: 25117958
Infect Dis Poverty. 2012 Dec 24;1(1):13
pubmed: 23849044
Sex Transm Dis. 2014 Feb;41(2):103-10
pubmed: 24413489
Health Policy Plan. 2013 Jul;28(4):347-57
pubmed: 22791556
AIDS Care. 2015;27(2):244-7
pubmed: 25062028
J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):e121-6
pubmed: 21963940
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S235-42
pubmed: 27429189
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv82-iv90
pubmed: 29194545
PLoS One. 2017 Aug 31;12(8):e0181919
pubmed: 28859083
Lancet Glob Health. 2020 Feb;8(2):e276-e287
pubmed: 31981557
J Acquir Immune Defic Syndr. 2018 Apr 15;77(5):476-483
pubmed: 29373391
PLoS One. 2018 Apr 10;13(4):e0194960
pubmed: 29634772
J Glob Health. 2016 Jun;6(1):010403
pubmed: 27231539
Bull World Health Organ. 2014 Jul 1;92(7):499-511AD
pubmed: 25110375
PLoS Med. 2020 Oct 7;17(10):e1003150
pubmed: 33027246
AIDS Behav. 2017 Mar;21(3):655-664
pubmed: 27654316
PLoS One. 2012;7(10):e46988
pubmed: 23071690
J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):e94-100
pubmed: 23535290
J Int AIDS Soc. 2019 Dec;22(12):e25436
pubmed: 31860172
AIDS. 2013 Oct;27 Suppl 1:S65-75
pubmed: 24088686
BJOG. 2012 Mar;119(4):431-8
pubmed: 22251303
Curr HIV/AIDS Rep. 2016 Jun;13(3):170-6
pubmed: 27221628
Int J MCH AIDS. 2017;6(1):36-45
pubmed: 28798892
Sex Transm Infect. 2016 Mar;92(2):130-4
pubmed: 26438349
Public Health Rep. 2016 Jan-Feb;131 Suppl 1:90-5
pubmed: 26862234
Reprod Health. 2019 May 29;16(Suppl 1):61
pubmed: 31138307
Soc Sci Med. 2016 Feb;151:147-56
pubmed: 26803655
J Altern Complement Med. 2017 May;23(5):326-330
pubmed: 28384006
Qual Life Res. 2012 May;21(4):613-23
pubmed: 21732198
Health Policy Plan. 2010 Mar;25(2):104-11
pubmed: 19917651
BMC Health Serv Res. 2011 Dec 21;11:346
pubmed: 22189090
Addict Sci Clin Pract. 2017 Aug 22;12(1):19
pubmed: 28826401
BMC Health Serv Res. 2014 Jan 23;14:32
pubmed: 24450409
PLoS Med. 2017 Oct 2;14(10):e1002397
pubmed: 28968399
Int J Drug Policy. 2018 Apr;54:105-113
pubmed: 29414482
Contraception. 2020 Jul;102(1):39-45
pubmed: 32298715
AIDS. 2012 Jul 31;26 Suppl 1:S19-30
pubmed: 22781175
PLoS Med. 2018 Mar 30;15(3):e1002547
pubmed: 29601570
Sociol Health Illn. 2021 Jan;43(1):167-185
pubmed: 33085116
PLoS One. 2015 May 15;10(5):e0126144
pubmed: 25978632
Int J Gynaecol Obstet. 2015 Jun;130 Suppl 2:S68-73
pubmed: 26115861
Stud Fam Plann. 2017 Jun;48(2):153-177
pubmed: 28337766
PLoS One. 2019 Jun 6;14(6):e0217331
pubmed: 31170193
J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):e123-9
pubmed: 26181813
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):472-479
pubmed: 28640065
BMC Public Health. 2011 Oct 10;11:780
pubmed: 21985434
J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):e92-8
pubmed: 22134144
AIDS. 2014 Mar;28 Suppl 2:S175-85
pubmed: 24849478
J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20013
pubmed: 26198348
Cost Eff Resour Alloc. 2018 Dec 4;16:63
pubmed: 30524207
J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S76-82
pubmed: 21317599
Trop Med Int Health. 2014 Mar;19(3):256-266
pubmed: 24433230
J Int AIDS Soc. 2016 Mar 11;19(1):20672
pubmed: 26976377
Sex Transm Infect. 2012 Mar;88(2):85-99
pubmed: 22158934
Trop Med Int Health. 2017 Aug;22(8):926-937
pubmed: 28544500
PLoS One. 2012;7(9):e44181
pubmed: 22970177
AIDS Care. 2014 Jan;26(1):87-94
pubmed: 23742681
Implement Sci. 2021 Apr 15;16(1):41
pubmed: 33858462
J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25296
pubmed: 31328443
J Clin Epidemiol. 2017 Sep;89:21-29
pubmed: 28365303
Psychiatr Serv. 2010 Sep;61(9):885-91
pubmed: 20810586
PLoS One. 2016 Nov 28;11(11):e0167308
pubmed: 27893864
AIDS Behav. 2017 Mar;21(3):703-711
pubmed: 27094787
Clin Infect Dis. 2020 Sep 12;71(6):1539-1546
pubmed: 31608373
Trop Med Int Health. 2010 Jun;15 Suppl 1:90-7
pubmed: 20586966
Public Health Action. 2015 Dec 21;5(4):209-13
pubmed: 26767172
PLoS One. 2020 May 6;15(5):e0231872
pubmed: 32374724
PLoS One. 2015 May 01;10(5):e0124476
pubmed: 25933414
PLoS One. 2018 Dec 7;13(12):e0208167
pubmed: 30532210
BMC Public Health. 2016 Aug 12;16:785
pubmed: 27519185
Science. 2013 Feb 22;339(6122):961-5
pubmed: 23430655
BMC Health Serv Res. 2016 Sep 20;16:494
pubmed: 27645152
PLoS One. 2015 May 19;10(5):e0127024
pubmed: 25993636
BMC Health Serv Res. 2013 Jun 07;13:207
pubmed: 23758816
Trop Med Int Health. 2011 Feb;16(2):193-9
pubmed: 21070513
Lancet Glob Health. 2020 Feb;8(2):e167-e168
pubmed: 31924538
J Clin Epidemiol. 2017 Sep;89:98-105
pubmed: 28363733
PLoS One. 2019 Nov 15;14(11):e0225104
pubmed: 31730630
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S87-95
pubmed: 25117965
PLoS Med. 2017 Feb 21;14(2):e1002240
pubmed: 28222126
PLoS One. 2013;8(3):e56550
pubmed: 23483887
Health Educ Res. 2006 Oct;21(5):688-94
pubmed: 16945984
BMC Public Health. 2019 Dec 3;19(1):1629
pubmed: 31795999
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv67-iv81
pubmed: 29194544
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219857724
pubmed: 31258023
J Midwifery Womens Health. 2011 Jul-Aug;56(4):395-399
pubmed: 21733112
Health Policy Plan. 2016 Oct;31(8):1050-7
pubmed: 27045002
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Health Policy Plan. 2010 Jan;25(1):1-14
pubmed: 19959485
Int J Gynaecol Obstet. 2017 Feb;136(2):220-228
pubmed: 28099724
J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e29-35
pubmed: 22395671
Lancet HIV. 2019 May;6(5):e283-e296
pubmed: 30952565
Sex Transm Dis. 2021 Mar 1;48(3):145-151
pubmed: 32976363
J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):e146-52
pubmed: 23288031
Lancet Infect Dis. 2011 Nov;11(11):855-67
pubmed: 22035614
Curr Opin HIV AIDS. 2019 Sep;14(5):366-373
pubmed: 31219888
Implement Sci. 2010 Jan 30;5:8
pubmed: 20205841
Int J Epidemiol. 2019 Aug 1;48(4):1327-1339
pubmed: 30879066
AIDS Behav. 2017 Mar;21(3):905-922
pubmed: 27807792
PLoS One. 2015 Apr 21;10(4):e0123275
pubmed: 25897491
BMJ Open Qual. 2020 Sep;9(3):
pubmed: 32928783
Lancet HIV. 2016 May;3(5):e202-11
pubmed: 27126487
Public Health Rep. 2014 Jan-Feb;129 Suppl 1:26-32
pubmed: 24385646
PLoS One. 2012;7(4):e35479
pubmed: 22545108
J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):e164-71
pubmed: 25886930
Clin Infect Dis. 2020 Dec 31;71(11):2968-2971
pubmed: 32424416
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):78-85
pubmed: 28991881
J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):e110-7
pubmed: 24091692
BMC Infect Dis. 2018 Oct 26;18(1):536
pubmed: 30367622
Hum Resour Health. 2014 Aug 07;12:42
pubmed: 25103923
Int J Tuberc Lung Dis. 2012 May;16(5):625-7
pubmed: 22417732
BMC Infect Dis. 2019 Jan 7;19(1):21
pubmed: 30616558
Public Health Action. 2016 Dec 21;6(4):255-260
pubmed: 28123964
PLoS One. 2010 Jul 13;5(7):e11522
pubmed: 20644629
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv48-iv56
pubmed: 28204500
Psychosomatics. 2012 Jan-Feb;53(1):51-7
pubmed: 22221721
BMC Health Serv Res. 2013 Jun 28;13:236
pubmed: 23809537
Ann Med Health Sci Res. 2015 Jul-Aug;5(4):253-9
pubmed: 26229713
PLoS One. 2017 Sep 7;12(9):e0184170
pubmed: 28880904
AIDS Care. 2013;25(7):795-804
pubmed: 23113572
J Acquir Immune Defic Syndr. 2014 Dec 1;67 Suppl 4:S259-70
pubmed: 25436826
AIDS. 2016 Sep 24;30(15):2341-50
pubmed: 27367487
AIDS Res Treat. 2019 May 2;2019:4170615
pubmed: 31186955
Front Public Health. 2017 Apr 10;5:71
pubmed: 28443275
PLoS One. 2019 Jun 21;14(6):e0218654
pubmed: 31226141
AIDS Patient Care STDS. 2016 May;30(5):208-14
pubmed: 27158848
Open Forum Infect Dis. 2017 May 04;4(3):ofx092
pubmed: 28695145
AIDS Behav. 2014 Apr;18(4):697-705
pubmed: 24122044
AIDS. 2013 Oct;27 Suppl 1:S87-92
pubmed: 24088688
AIDS. 2017 Sep 10;31(14):1999-2006
pubmed: 28692543
AIDS. 2021 May 1;35(6):911-919
pubmed: 33821821
Sex Transm Dis. 2011 May;38(5):401-9
pubmed: 21317689
AIDS. 2018 Jul 1;32 Suppl 1:S63-S73
pubmed: 29952792
Afr J Reprod Health. 2017 Jun;21(2):73-80
pubmed: 29624942
Lancet. 2018 Jul 28;392(10144):312-358
pubmed: 30032975
Lancet. 2015 Jan 10;385(9963):186-99
pubmed: 25059943
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7952-7
pubmed: 23589884
BMJ Open. 2016 Mar 06;6(3):e009656
pubmed: 26948960
J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):458-466
pubmed: 30085953
J Hepatol. 2020 Jan;72(1):67-74
pubmed: 31604081
Stat Med. 2002 Feb 28;21(4):589-624
pubmed: 11836738
Int J Womens Health. 2017 Feb 02;9:69-79
pubmed: 28203108
Bull World Health Organ. 2015 Jan 1;93(1):52-6
pubmed: 25558108
PLoS One. 2013 Nov 28;8(11):e80951
pubmed: 24312253
BMC Infect Dis. 2019 Jul 25;19(1):663
pubmed: 31345169
Public Health Action. 2015 Mar 21;5(1):36-44
pubmed: 26400600
J Int AIDS Soc. 2014 Jul 28;17:18994
pubmed: 25079437
J Clin Epidemiol. 2011 Apr;64(4):383-94
pubmed: 21195583
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD003318
pubmed: 21735392
Lancet. 2018 Sep 1;392(10149):747-759
pubmed: 30191830
AIDS Care. 2018 Jan;30(1):103-115
pubmed: 28679283
J Int AIDS Soc. 2017 May 30;20(1):21585
pubmed: 28692211